At a glance

ClinicalIndex Comparison Record

N/ACompleted· 20 enrolled

Drug / intervention

PRP +1 moreprocedure

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03526913

NCT03526913N/ACompleted

Compare CT.gov

Role of Platelet Rich Plasma in Enhancing Graft Take in Chronic Venous Ulcers

Noha Mohsen Omar·interventional·Posted May 16, 2018·Updated May 18, 2018

In Brief

A clinical study evaluating PRP and STSG for Chronic Venous Hypertension With Ulcer and Inflammation and Chronic Ulcer of Leg or Foot. Completed, enrolled 20 participants.

Detailed Summary

Chronic venous ulcers are considered a problem with a big morbidity impact on both the health facilities and patients, skin-grafting have shown not so perfect outcomes with such ulcers. In this study, the investigators compare combining autologous platelet rich plasma treatments with partial skin grafting in chronic ulcers, the results were compared to using only partial skin grafting, and among various types of chronic resistant ulcers.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsChronic Venous Hypertension With Ulcer and Inflammation, Chronic Ulcer of Leg or Foot

Countries--

CollaboratorsMenoufia University

Timeline

N/ACompletedFinished

20162017201820192020202120222023202420252026

Enrollment StartFeb 2016

Primary CompletionSep 2017

Study CompletionFeb 2018

First PostedMay 2018

TodayJul 2026

First PostedMay 16, 2018

Enrollment StartFeb 1, 2016

Primary CompletionSep 1, 2017

Study CompletionFeb 1, 2018

TodayJul 2, 2026

Enrollment to primary: 1.6 yearsPosted 8.1 years ago

Interventions

PRPprocedure

PRP: autologous platelet-rich plasma

STSGprocedure

skin graft: Split Thickness Skin Grafting (STSG)